In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...

As medications become increasingly popular to support weight loss, not all of them are approved by the U.S. Food and Drug ...

These headaches are typically a result of how the drug interacts with your body, not a direct effect of the medication.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

The pop star was performing the 2014 hit during iHeartRadio’s KIIS-FM Wango Tango Saturday when she made the surprising ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss ...

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...

A survey shows Gen Z favoring weight loss drugs like Ozempic and Wegovy over exercise and diet for reaching their weight loss ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...